Markus Lungen

Summary

Affiliation: University of Cologne
Country: Germany

Publications

  1. doi [Convergence tendencies in inpatient oncological care after implementation of diagnosis-related groups in Germany]
    M Lungen
    Institut für Gesundheitsökonomie und Klinische Epidemiologie der Universität zu Köln, Koln
    Gesundheitswesen 71:809-15. 2009
  2. doi [Analysis of selection inventives for health insurances after introduction of the morbidity-oriented risk compensation scheme: an empirical analysis]
    M Lungen
    Institut für Gesundheitsökonomie und Klinische Epidemiologie der Universität zu Köln
    Gesundheitswesen 72:790-6. 2010
  3. doi [Analysis and evaluation of the QUALIFY tool for assessing quality indicators with structured group interviews]
    Markus Lungen
    Institut für Gesundheitsökonomie und Klinische Epidemiologie der Universität zu Köln
    Z Evid Fortbild Qual Gesundhwes 105:38-43. 2011
  4. doi [Does the lack of evidence of effectiveness among international studies on interventions in prevention and health promotion have an impact on a German Act of Prevention?]
    Markus Lungen
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Universitat zu Koln, Koln, Germany
    Med Klin (Munich) 104:101-7. 2009
  5. pmc Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany
    Markus Lungen
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Gleueler Str, 176 178, D 50935 Cologne, Germany
    Int J Equity Health 7:1. 2008
  6. doi Financial incentives in the German Statutory Health Insurance: new findings, new questions
    Stephanie Stock
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Gleueler Strasse 176 178, Koln, Germany
    Health Policy 96:51-6. 2010
  7. ncbi [DRG in the context of current health policy]
    Karl W Lauterbach
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Universitat zu Koln, Cologne
    Med Klin (Munich) 98:467-71. 2003
  8. ncbi Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance
    Stephanie Stock
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Germany
    Int J Public Health 53:78-86. 2008
  9. doi Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany
    Andreas Gerber
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany
    Am J Geriatr Pharmacother 6:212-9. 2008
  10. doi Substitution of theophylline slow-release formulations according to the rebate contracts in the German statutory health insurance
    Jörn Weissenfeld
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Koln, Germany
    Arzneimittelforschung 59:476-81. 2009

Collaborators

Detail Information

Publications15

  1. doi [Convergence tendencies in inpatient oncological care after implementation of diagnosis-related groups in Germany]
    M Lungen
    Institut für Gesundheitsökonomie und Klinische Epidemiologie der Universität zu Köln, Koln
    Gesundheitswesen 71:809-15. 2009
    ..So far, estimates of the extent to which this effect occurs after the recent implementation of DRGs are not available in Germany...
  2. doi [Analysis of selection inventives for health insurances after introduction of the morbidity-oriented risk compensation scheme: an empirical analysis]
    M Lungen
    Institut für Gesundheitsökonomie und Klinische Epidemiologie der Universität zu Köln
    Gesundheitswesen 72:790-6. 2010
    ....
  3. doi [Analysis and evaluation of the QUALIFY tool for assessing quality indicators with structured group interviews]
    Markus Lungen
    Institut für Gesundheitsökonomie und Klinische Epidemiologie der Universität zu Köln
    Z Evid Fortbild Qual Gesundhwes 105:38-43. 2011
    ..In this context group interviews could provide an applicable approach to evaluating acceptance and implementation problems...
  4. doi [Does the lack of evidence of effectiveness among international studies on interventions in prevention and health promotion have an impact on a German Act of Prevention?]
    Markus Lungen
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Universitat zu Koln, Koln, Germany
    Med Klin (Munich) 104:101-7. 2009
    ..To date, no consensus could be reached with changing political majorities in parliament. Hence, the authors ask the question whether the lack of evidence in prevention and health promotion could also be contributing to this delay...
  5. pmc Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany
    Markus Lungen
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Gleueler Str, 176 178, D 50935 Cologne, Germany
    Int J Equity Health 7:1. 2008
    ..There is little empirical evidence regarding outpatient waiting times for patients with different health insurance status in Germany...
  6. doi Financial incentives in the German Statutory Health Insurance: new findings, new questions
    Stephanie Stock
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Gleueler Strasse 176 178, Koln, Germany
    Health Policy 96:51-6. 2010
    ..Its objective is to describe the rationale behind the programs, analyze their financial impact and discuss their implications on potentially conflicting goals on solidarity and competition...
  7. ncbi [DRG in the context of current health policy]
    Karl W Lauterbach
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Universitat zu Koln, Cologne
    Med Klin (Munich) 98:467-71. 2003
  8. ncbi Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance
    Stephanie Stock
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Germany
    Int J Public Health 53:78-86. 2008
    ..The aim of this study was to investigate the financial implications of a prevention bonus program from a sickness fund perspective...
  9. doi Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany
    Andreas Gerber
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany
    Am J Geriatr Pharmacother 6:212-9. 2008
    ..The aim of this study was to quantify and classify errors associated with the repackaging of residents' medications in long-term care facilities in Germany...
  10. doi Substitution of theophylline slow-release formulations according to the rebate contracts in the German statutory health insurance
    Jörn Weissenfeld
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Koln, Germany
    Arzneimittelforschung 59:476-81. 2009
    ..Nevertheless, the question remains as to whether the costs saved by the rebate contracts would not be significantly outweighed...
  11. doi German diabetes management programs improve quality of care and curb costs
    Stephanie Stock
    Institute of Health Economics and Clinical Epidemiology, University Hospital Cologne, in Germany
    Health Aff (Millwood) 29:2197-205. 2010
    ..These results suggest that the German disease management program is a successful strategy for improving chronic illness care...
  12. ncbi The reform of hospital financing in Germany: an international solution?
    Markus Lungen
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany
    J Health Organ Manag 17:360-72. 2003
    ..The manner, scope and timing of this reform suggests that it will not succeed. Reforms lead to yet more reforms...
  13. doi Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany
    Janina Mertens
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Cologne University, Cologne, Germany
    Pediatr Allergy Immunol 23:597-604. 2012
    ..The objective was to assess the cost-effectiveness of feeding hydrolyzed formulas...
  14. doi Direct non-medical and indirect costs for families with children with congenital cardiac defects in Germany: a survey from a university centre
    Andreas U Gerber
    Institute for Health Economics and Clinical Epidemiology, University of Cologne, Gleueler Strasse, Cologne, Germany
    Cardiol Young 20:178-85. 2010
    ..Parents of children with congenital cardiac disease suffer from psychological stress and financial burdens. These costs have not yet been quantified...
  15. ncbi [Effectiveness of structural quality in quality assurance--a review]
    Markus Lungen
    Institut fur Gesundheitsokonomie und Klinische Epidemiologie, Universitat zu Koln
    Z Arztl Fortbild Qualitatssich 96:101-14. 2002
    ..Minimum standards as a part of structural quality are often discussed for the sake of improving the quality of medical care. Before implementing obligatory standards, however, the effectiveness of the demands made should be evaluated...